Skip to content

Measure of Acceptance of chRonic Visible sKin conditionS

Acceptance Des Maladies Chroniques Dermatologiques Visibles : Constitution d'échelles Pour le Patient et Son Cluster Familial

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06103903
Acronym
MARKS
Enrollment
250
Registered
2023-10-27
Start date
2022-01-01
Completion date
2025-12-31
Last updated
2023-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acceptance of Visible Chronic Dermatological Disease, Disease Acceptance, Psychological Well-Being, Social Segregation

Keywords

Chronic dermatological disease, Psychology, Sociology, Disease Acceptance, Vitiligo, port wine stain, hyperpigmentation, alopecia areata

Brief summary

The objective of this protocol is to validate 4 scales for evaluating the acceptance of visible chronic dermatological diseases (port wine stains, alopecia areata, vitiligo, hyperpigmentation...) with a large number of patients (children, adolescents, adults) and their parents (depending on the composition of the family cluster), in a multicentric manner (for territorial representativeness).

Detailed description

The objective of this protocol is to validate 4 scales for evaluating the acceptance of visible chronic dermatological diseases (port wine stains, alopecia areata, vitiligo, hyperpigmentation...) with a large number of patients (children, adolescents, adults) and their parents (depending on the composition of the family cluster), in a multicentric manner (for territorial representativeness). The investigator will screen the patients and give them a link to complete the questionnaire (according to the age), that includes a pre-scale of acceptation of 50-55 items.

Interventions

BEHAVIORALQuestionnaire

Questionnaire according to age (6-13;14-17); the parents for minors and adults

Sponsors

INSERM UMR 1246 SPHERE
CollaboratorUNKNOWN
University Hospital, Tours
Lead SponsorOTHER

Study design

Observational model
FAMILY_BASED
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Years to No maximum

Inclusion criteria

1. Targeted pathologies: * Flat angioma * Primary hypopigmentation and early vitiligo * Primary hyperpigmentation * Refractory alopecia areata or congenital alopecia 2. Persons concerned: * Children (≥ 6 years old) suffering from one of the aforementioned pathologies * Adults suffering from one of the above-mentioned pathologies * Parents of children suffering from one of the aforementioned pathologies * Parents of young adult patients if they live under the same roof 3. Oral agreement for each person (major/minor) and, where applicable, one of the holders of parental authority (minor)

Exclusion criteria

1. Secondary marks (post-inflammatory, post-medication, post-traumatic, etc.) 2. Major psychiatric disorders

Design outcomes

Primary

MeasureTime frameDescription
Questionnaire analysisUp to 4 weeksAnalysis of responses to the 4 questionnaires (scales) evaluating the acceptance of chronic dermatological diseases visible in children, adolescents, adults and parents, respectively.

Countries

France

Contacts

Primary ContactAnnabel MARUANI, MD-PhD
annabel.maruani@univ-tours.fr+33 (0)247479076

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026